47 results on '"Enzymes -- Intellectual property"'
Search Results
2. Patent Application Titled 'Analogs For The Treatment Of Disease' Published Online (USPTO 20240336611)
3. Researchers Submit Patent Application, 'Compositions For Treating And/Or Preventing Cell Or Tissue Necrosis Specifically Targeting Cathepsin C And/Or Cela1 And/Or Cela3a And/Or Structurally Related Enzymes Thereto', for Approval (USPTO 20240294
4. Researchers Submit Patent Application, 'Antibody-Urease Conjugates For Therapeutic Purposes', for Approval (USPTO 20240277863)
5. Patent Issued for Substituted quinolines and formulations thereof (USPTO 12017996)
6. Patent Application Titled 'Small-Molecule-Activated Glycan Modifying Enzymes And Uses Thereof' Published Online (USPTO 20240209334)
7. Researchers Submit Patent Application, 'Engineered Acetate Kinase Variant Enzymes', for Approval (USPTO 20240150733)
8. Researchers Submit Patent Application, 'Engineered Uridine Phosphorylase Variant Enzymes', for Approval (USPTO 20240132858)
9. Patent Application Titled 'Modulators Of Methyl Modifying Enzymes, Compositions And Uses Thereof' Published Online (USPTO 20240116905)
10. Researchers Submit Patent Application, 'Phosphorothioate Nucleic Acid Conjugates Including Dna Editing Enzymes', for Approval (USPTO 20240110176)
11. Patent Issued for Engineered acetate kinase variant enzymes (USPTO 11913036)
12. Patent Issued for Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity (USPTO 11905522)
13. Researchers Submit Patent Application, 'Improved Assays To Detect Nucleosome Modifications Using Antibody-Targeted Enzyme Digestion', for Approval (USPTO 20230417742)
14. Patent Application Titled 'Therapeutic Conjugates' Published Online (USPTO 20230405135)
15. Patent Issued for Anti-tumor immunotherapy enhancer (USPTO 11752150)
16. Researchers Submit Patent Application, 'Engineered Cells Secreting Therapeutic Enzymes', for Approval (USPTO 20230174944)
17. Patent Issued for Prodrug-type anticancer agent using cancer-specific enzymatic activity (USPTO 11655269)
18. Patent Issued for Human kynureninase enzymes and uses thereof (USPTO 11648272)
19. Patent Issued for Analogs for the treatment of disease (USPTO 11530197)
20. Patent Issued for Analogs for the treatment of disease (USPTO 11530199)
21. Patent Application Titled 'Degradable Multi-Arm Polyethylene Glycol Derivative' Published Online (USPTO 20220380533)
22. Patent Application Titled 'Use Of Hsp70 As A Regulator Of Enzymatic Activity' Published Online (USPTO 20220362234)
23. Researchers Submit Patent Application, 'Engineered Guanylate Kinase Variant Enzymes', for Approval (USPTO 20220325284)
24. Researchers Submit Patent Application, 'Engineered Acetate Kinase Variant Enzymes', for Approval (USPTO 20220325256)
25. 'Engineered Adenylate Kinase Variant Enzymes' in Patent Application Approval Process (USPTO 20220325257)
26. 'ENGINEERED CYCLIC GMP-AMP SYNTHASE (cGAS) VARIANT ENZYMES' in Patent Application Approval Process (USPTO 20220325285)
27. Patent Issued for Modulators of methyl modifying enzymes, compositions and uses thereof (USPTO 11459315)
28. Patent Issued for Modulators of methyl modifying enzymes, compositions and uses thereof (USPTO 11274095)
29. 'Usp7 Inhibition' in Patent Application Approval Process (USPTO 20210347761)
30. Patent Issued for Enzyme-directed immunostimulant and uses thereof (USPTO 11117918)
31. Patent Application Titled 'Modulators Of Methyl Modifying Enzymes, Compositions And Uses Thereof' Published Online (USPTO 20210230148)
32. Patent Issued for Nicotinamide riboside compositions for topical use in treating skin conditions (USPTO 11033568)
33. Patent Application Titled 'Prodrug-Type Anticancer Agent Using Cancer-Specific Enzymatic Activity' Published Online (USPTO 20200399305)
34. 'Anti-Tumor Immunotherapy Enhancer' in Patent Application Approval Process (USPTO 20200383981)
35. Patent Issued for Salt Forms Of 4-Cyano-N-(4,4-Dimethylcyclohex-1-En-1-Yl)-6-(2,2,6,6-Tetr amethyltetrahydro-2H-Pyran-4-Yl)pyridin-3-Yl)-1H-Imidazole-2-Carboximide (USPTO 10,858,348)
36. Researchers Submit Patent Application, 'Nicotinamide Riboside Compositions For Topical Use In Treating Skin Conditions', for Approval (USPTO 20200289536)
37. 'Enzyme-Directed Immunostimulant And Uses Thereof' in Patent Application Approval Process (USPTO 20200199166)
38. Patent Issued for Modulators Of Methyl Modifying Enzymes, Compositions And Uses (USPTO 10,689,371)
39. 'Detection Of Disease Or Pathogen Related Enzymes Using Ferrocene Sensor Modified Electrodes' in Patent Application Approval Process (USPTO 20200158681)
40. Patent Issued for Compounds For Cancer Chemotherapeutic Sensitization (USPTO 10,617,706)
41. Researchers Submit Patent Application, 'Non-Invasive Enzyme Screen For Tissue Remodelling-Associated Conditions', for Approval (USPTO 20200057066)
42. Patent Application Titled 'Compounds For Cancer Chemotherapeutic Sensitization' Published Online (USPTO 20190240244)
43. Reports from Department of Pharmaceutical Biotechnology Advance Knowledge in Biotechnology Patents (Arginine Deiminase: Current Understanding and Applications)
44. Researchers Submit Patent Application, 'Deuterium-Substituted Quinoline Derivatives', for Approval (USPTO 20190062307)
45. Patent Issued for Mitochondrial Enoyl Coenzyme a Hydratase 1 as Marker for Diagnosing Stomach Cancer
46. Patent Issued for Solubilized Topoisomerase Poisons
47. New hydro-lyases study findings have been reported from Griffith University, Eskitis Institute for Cell and Molecular Therapies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.